Purchase Order 75F40122P00466
Award Date
9/9/22
Potential Completion Date
9/20/23
Potential Value
$114K
Federal Agency
Food and Drug Administration
Awardee
Certara UK LIMITED
Ultimate Awardee
Not listed
NAICS Category
511210 - Software Publishers
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Certara UK LIMITED, doing business as Certara, a for-profit limited liability company. The $815,948.00 contract is for Certara's SIMCYP software licenses, which provide physiologically-based pharmacokinetic (PBPK) modeling capabilities to facilitate regulatory decision-making and optimize drug development. The SIMCYP software is used by the FDA's Office of...
The Environmental Protection Agency Office of Research and Development awarded a $12,390.00 firm-fixed-price purchase order to Certara UK LIMITED, doing business as Certara, a for-profit limited liability company. The contract is for the renewal of a software license for Certara's SIMCYP physiologically-based pharmacokinetic modeling software. Certara has previously provided this software to the Department of Health and Human Services Food and Drug Administration and the Environmental Protection...
This federal contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), is for $83,806.57 to provide Certara Phoenix software licenses for pharmacokinetic modeling and simulation. The contract is a firm fixed-price purchase order with a completion date of August 31, 2026. Certara is a technology-enabled drug development and drug safety consultancy that has received numerous prior federal contract...
The Department of Health and Human Services' Food and Drug Administration awarded a $43,243.20 firm fixed price purchase order to Certara USA Inc. for SEND EXPLORER licenses. The place of performance is Silver Spring, Maryland. The one-year contract runs from September 12, 2023 through September 14, 2024. Certara USA Inc. will provide the FDA with software licenses to support the agency's regulatory science and public health protection missions. No subcontractors or set asides were identified....
This is a $169,504.71 firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), a technology-enabled drug development and drug safety consultancy. The contract provides annual named user server licenses for Certara's Phoenix WinNonlin, Phoenix Connect, Phoenix NLME software, as well as an unlimited server license for distributed computing. This supports the FDA's...
This is a $91,396 firm fixed-price purchase order issued by the Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (De), for the ratification of Phoenix Quantum licenses in fiscal year 2017. Certara is a technology-enabled drug development and drug safety consultancy that specializes in biosimulation and has received multiple federal contracts from the Department of Health and Human Services, including the FDA, National Institutes of Health, and Centers for...
The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...
This federal contract award to Certara USA Inc., doing business as Tripos (De), is for the provision of SEND Explorer Plus software licenses and annual maintenance services to the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services. The $129,832.56 firm fixed-price purchase order has a period of performance through September 29, 2025. Certara is a technology-enabled drug development and drug safety consultancy that specializes in...
This firm-fixed-price purchase order awards Simulations Plus Inc., doing business as Simulations Plus, a contract valued at $375,965.05 to provide software licenses for GastroPlus, DDDPlus, and MembranePlus to the Food and Drug Administration (FDA). These software products are used for physiologically-based pharmacokinetic (PBPK) modeling, predicting drug absorption and pharmacokinetics, and conducting virtual bioequivalence studies to support pharmaceutical research, development, and regulatory...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc., a small business for-profit software company, for the procurement of GastroPlus software licenses. The $252,421.24 contract provides the FDA access to Simulations Plus' physiologically-based pharmacokinetic (PBPK) modeling and simulation software, which supports research and regulatory decision-making in pharmaceutical development and assessment. The award does not appear to be...